Progesterone receptor gene variants and risk of endometrial cancer. - Wikidata - wikimedia - TriplyDB

Progesterone receptor gene variants and risk of endometrial cancer.

Progesterone receptor gene variants and risk of endometrial cancer.

http://www.wikidata.org/entity/Q35018327

about

CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk.Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.Single nucleotide polymorphism of SREBF-1 gene associated with an increased risk of endometrial cancer in Chinese women.Breast cancer susceptibility polymorphisms and endometrial cancer risk: a Collaborative Endometrial Cancer Study.Rare variants in the ATM gene and risk of breast cancer Genome-wide association study identifies a possible susceptibility locus for endometrial cancer Association of progesterone receptor gene (PGR) variants and breast cancer risk in African American women.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.Association of the +331G/A progesterone receptor gene (PgR) polymorphism with risk of endometrial cancer in Caucasian women: a meta-analysis.Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

P2860

Q33994241-5CBE4516-BD63-4AE1-A2EE-0C13CFED115E Q34562166-F1959F2F-49A9-4565-BD84-06AF56F0E2D2 Q34727321-67926938-C576-4148-AFFF-C191A440C413 Q35116087-9AC40604-4DCF-4822-B635-0EBE696AACD2 Q35562912-AA30CA8B-83E6-4C27-ABAA-42BA99D56E29 Q35608690-F89EE92B-7DF4-43AB-8CF1-20CCBA1AA30B Q36024614-643730A4-DD8C-46B9-9DF8-D566DC9AB085 Q37260827-7E53C557-B39B-4B79-8314-6FDAE9DB90F1 Q38788210-FB8A1ADC-233A-400A-A4A1-121DFF43CE2F Q44636781-5F1248E9-90DD-40B8-A832-17412266E760 Q55297932-E5967189-4B0B-43DF-ACA2-E4CC2DA3FCA3

P2860

Progesterone receptor gene variants and risk of endometrial cancer.

http://www.wikidata.org/entity/Q35018327

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Progesterone receptor gene variants and risk of endometrial cancer.

@ast

Progesterone receptor gene variants and risk of endometrial cancer.

@en

type

label

Progesterone receptor gene variants and risk of endometrial cancer.

@ast

Progesterone receptor gene variants and risk of endometrial cancer.

@en

prefLabel

Progesterone receptor gene variants and risk of endometrial cancer.

@ast

Progesterone receptor gene variants and risk of endometrial cancer.

@en

P1433

Q35018327-ADDDDCD0-11F5-40F8-82BA-F2BB0257B87F

P1476

Q35018327-9481D77D-F764-4D27-8B78-796339E1B0AD

P2093

Q35018327-0CF108D1-3785-4496-8818-E6D9CD9BE9F4

Q35018327-16902993-04DA-4417-AE36-2A977A4EEB92

Q35018327-2F87117A-C5A1-4D0A-AC72-E9C84FF3EB09

Q35018327-4F868198-A517-4E3E-978F-E52F4D157903

Q35018327-6F1AAC4E-FA2E-4290-AA47-F0B24780A17A

Q35018327-75A86762-568F-4186-AB83-75F9092BE628

Q35018327-7FB8F4B7-EA5C-4411-B8A9-B06E71B38741

Q35018327-86D88786-7C4E-4C43-AFF7-ED5E861859A2

Q35018327-A3C3377C-E69D-47D2-B39F-D02E4102C23E

Q35018327-B2CAE011-D451-4A76-8569-36E0C75AB5CF

P2860

Q35018327-13647E5B-9A99-4309-A3D7-5FECFD6F2F6C

Q35018327-2DE988AF-409F-48E2-A08D-8AF414C19756

Q35018327-2F2C0108-7FE5-4F02-B966-6D7E2C6EB1B8

Q35018327-34BAD658-3197-4527-8D23-CC5A39AEE079

Q35018327-390C9546-D76C-4426-9C73-5F90CAAEC684

Q35018327-4380E880-B7E4-4492-B972-AD260CA7B1C9

Q35018327-4ACF6CC9-AA3D-482F-84C9-BCC0AD898F67

Q35018327-4EBA8550-98AF-4A36-BC45-FC8642779225

Q35018327-566ED44F-F951-41A9-BB17-0A6028696430

Q35018327-59E7714D-B10A-4D87-9A2C-460C727F2025

P304

Q35018327-329FE07A-D025-40B8-BCCD-1ABA9E784ED4

P31

Q35018327-89245EB4-A981-4F11-9699-57578DF9C538

P356

Q35018327-DED4B02E-5C21-421F-BD1C-2CE0E0AF4CCB

P407

Q35018327-86AEAB2A-76B4-431F-85B8-227D4C88BF8A

P433

Q35018327-15ED8BCD-E3F6-418D-89A8-F2EE3CEB57A7

P478

Q35018327-2F999E0C-2B5A-4FD1-9730-E8713EC9DB82

P50

Q35018327-02D9B12F-9008-4051-BADF-4A8F59308CE6

Q35018327-12E870F2-9B36-4D2D-AEFE-8D82CD76572F

Q35018327-3506AD1D-61A1-4098-8FCF-CCDFEF5241F7

Q35018327-4BF80F8E-6A4F-419B-B882-266F9D2397CA

Q35018327-6B25137F-91EB-48A2-B502-3FEFC348EE5A

Q35018327-6C22D9E1-D9C8-4C84-B5BB-7D23B0D1636E

Q35018327-75C5F265-BAAF-4508-A19C-E1D767ADA7E7

Q35018327-7842B91D-E23A-4E15-B741-E9F24A761F07

Q35018327-99C9007A-2599-45A0-B58C-CAEB52404DD6

Q35018327-C953CD56-90FB-47C5-96BF-67AF016005C4

P577

Q35018327-A6F666A7-DE28-40A3-BEC6-0B5CA3104294

P5875

Q35018327-3B6D516B-D592-4A60-B9FF-C7ED2F02DC9B

P698

Q35018327-B3A0BEAD-D2F1-4AF2-9F8C-A2B2B4BDBDF2

P932

Q35018327-E2FB272E-9F84-477D-A6A0-3CDF827508F5

P356

P1433

P1476

Progesterone receptor gene variants and risk of endometrial cancer.

@en

P2093

ANECS

http://www.w3.org/2001/XMLSchema#string

AOCS Management Group

http://www.w3.org/2001/XMLSchema#string

Catherine S Gregory

http://www.w3.org/2001/XMLSchema#string

Evelyn Despierre

http://www.w3.org/2001/XMLSchema#string

Frederic Amant

http://www.w3.org/2001/XMLSchema#string

Kaltin Ferguson

http://www.w3.org/2001/XMLSchema#string

Louise Marquart

http://www.w3.org/2001/XMLSchema#string

Mitul Shah

http://www.w3.org/2001/XMLSchema#string

SASBAC

http://www.w3.org/2001/XMLSchema#string

SEARCH

http://www.w3.org/2001/XMLSchema#string

P2860

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.

Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B

Genetic variation in the progesterone receptor gene and risk of endometrial cancer: a haplotype-based approach.

No association between progesterone receptor gene +331G/A polymorphism and endometrial cancer.

Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.

Cancer control in women. Update 2003.

The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.

Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.

Biological roles of estrogen and progesterone in human endometrial carcinoma--new developments in potential endocrine therapy for endometrial cancer.

Association between single-nucleotide polymorphisms in hormone metabolism and DNA repair genes and epithelial ovarian cancer: results from two Australian studies and an additional validation set.

P304

331-335

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGQ263

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Diether Lambrechts

Penelope M. Webb

Amanda B. Spurdle

P577

2010-12-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49674491

http://www.w3.org/2001/XMLSchema#string

P698

21148628

http://www.w3.org/2001/XMLSchema#string

P932

3105584

http://www.w3.org/2001/XMLSchema#string